Latest News for: Information stockholm

Edit

Cantargia Publishes Annual Report for 2023

Pharmiweb 18 Apr 2024
Cantargia (Cantargia AB; Nasdaq Stockholm.CANTA) today announced that the annual report for 2023 has been published ... For further information, please contact. ... Cantargia is listed on Nasdaq Stockholm (ticker.
Edit

Notice of Annual General Meeting in Cantargia AB (publ)

Pharmiweb 18 Apr 2024
When giving notice, the shareholder shall state name, personal or corporate registration number, address, telephone number and the number of any accompanying assistant(s) (maximum two assistants) as well as information about any proxy.
Edit

Cantargia Publishes New Data on the CAN10 Antibody, Detailing its Interaction with IL1RAP and Functional Inhibition

Pharmiweb 17 Apr 2024
For further information, please contact ... Cantargia is listed on Nasdaq Stockholm (ticker ... More information about Cantargia is available at www.cantargia.com.
Edit

IRLAB to Present at Redeye Investor Forum

Pharmiweb 16 Apr 2024
GOTHENBURG, SWEDEN / ACCESSWIRE / April 16, 2024 / IRLAB Therapeutics (STO.IRLAB-A)(FRA.6IRA) Gothenburg, Sweden, April 16, 2024 - IRLAB Therapeutics AB (Nasdaq Stockholm ... For more information ... For more information, please visit www.irlab.se.
Edit

Vicore to Present at Upcoming Investor Conferences

Pharmiweb 12 Apr 2024
For further information, please contact. ... This information was submitted for publication on April 12, 2024, at 11.00 CET ... The company's shares (VICO) are listed on Nasdaq Stockholm's main market. For more information, see www.vicorepharma.com .
Edit

Quantum behavior at room temperature: When laser light makes materials magnetic

Phys Dot Org 10 Apr 2024
The breakthrough is expected to pave the way for faster and more energy-efficient computers, information transfer and data storage ... The breakthrough is expected to have broad applications in several information technologies ... More information.
Edit

Cantargia Publishes Preclinical Data on the Potential of CAN10 in Systemic Sclerosis in a Leading Scientific Journal

Pharmiweb 10 Apr 2024
For further information, please contact ... Cantargia is listed on Nasdaq Stockholm (ticker ... More information about Cantargia is available at www.cantargia.com.
Edit

Ocean waves propel PFAS back to land, new study finds

Phys Dot Org 05 Apr 2024
More information ... Journal information ... Provided by Stockholm University ... The content is provided for information purposes only.
Edit

Notice of Annual General Meeting of Vicore Pharma Holding AB (publ)

Pharmiweb 04 Apr 2024
STOCKHOLM, SWEDEN / ACCESSWIRE / April 4, 2024 / Vicore Pharma Holding (STO.VICO) The shareholders of Vicore Pharma Holding AB (publ), Reg ... Nina Carlén, Kornhamnstorg 53, SE-111 27 Stockholm, Sweden, or via e-mail to nina.carlen@vicorepharma.com.
Edit

Cantargia Publishes Data Highlighting the Potential of CAN10 in Atherosclerosis

Pharmiweb 02 Apr 2024
For further information, please contact ... Cantargia is listed on Nasdaq Stockholm (ticker ... More information about Cantargia is available at www.cantargia.com .
Edit

Vicore Announces Presentations at the 2024 American Thoracic Society International Conference

Pharmiweb 28 Mar 2024
For further information, please contact. ... This information was submitted for publication on March 28, 2024, at 08.00 CET ... The company's shares (VICO) are listed on Nasdaq Stockholm's main market. For more information, see www.vicorepharma.com.
Edit

Vicore Publishes the Annual Report for 2023

Pharmiweb 27 Mar 2024
STOCKHOLM, SWEDEN / ACCESSWIRE / March ... For further information, please contact. ... The company's shares (VICO) are listed on Nasdaq Stockholm's main market. For more information, see www.vicorepharma.com.
Edit

Oncopeptides and Vector Pharma FZCO Announce Collaboration to Provide Pepaxti to Patients in the Middle East and North Africa

Pharmiweb 27 Mar 2024
Stockholm, Sweden and Dubai, UAE, March 27, 2024 – Oncopeptides AB (STO ... More information can be found at www.vectorpharma.me or at custops@vectorpharma.me ... For more information see.
Edit

Cantargia Reports Progress Towards Start of DOD-Sponsored Clinical Trial of Nadunolimab in Leukemia

Pharmiweb 27 Mar 2024
LUND, SWEDEN / ACCESSWIRE / March 27, 2024 / Cantargia (STO.CANTA) Cantargia (Cantargia AB; Nasdaq Stockholm ... For further information, please contact ... Cantargia is listed on Nasdaq Stockholm (ticker.
Edit

Eco (Atlantic) Oil and Gas Ltd Announces Holding(s) in Company

ACCESSWIRE 26 Mar 2024
Place of completion Stockholm, Sweden Date of completion 26-03-2024 This information is provided by RNS, the news service of the London Stock Exchange ... Terms and conditions relating to the use and distribution of this information may apply.
×